Skip to main content

The EU outlined its plan to equalize drug access and lower prices. Pharma firms are not happy

A proposal for the biggest shake-up in pharma rules for decades has finally arrived, but companies say they could take their innovative medicines elsewhere.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.